Adagio Medical Holdings, Inc. (ADGM) vs bioAffinity Technologies, Inc. (BIAF)

A side-by-side comparison of Adagio Medical Holdings, Inc. and bioAffinity Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Adagio Medical Holdings, Inc. logo
ADGM
Adagio Medical Holdings, Inc.
$3M
$0.14HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
bioAffinity Technologies, Inc. logo
BIAF
bioAffinity Technologies, Inc.
$3M
$6.19HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — ADGM vs BIAF

growth of $100 · dividends reinvested · last 2y
ADGM -98.4% (-87.5%/yr)BIAF -99.4% (-92.4%/yr)ADGM compounded faster over this window
020406080100Start $10020252026$2$1
ADGM BIAF

ADGM vs BIAF: by the numbers

  • •ADGM is the larger company ($3M vs $3M market cap).
  • •Both run net losses; ADGM's is the smaller (0.00% vs -257.33% net margin).

Metrics side by side

Valuation

MetricADGMBIAF
P/S ratioN/A0.44
P/B ratioN/A0.69

Profitability

MetricADGMBIAF
Gross margin0.00%23.21%
Operating margin0.00%-171.58%
Net margin0.00%-257.33%
ROEN/A-402.92%
ROIC-75.31%-237.93%

Go deeper

Full ADGM analysisFull BIAF analysisInteractive comparison tool

Dig into the metrics

Adagio Medical ROEbioAffinity Technologies ROEAdagio Medical operating marginbioAffinity Technologies operating marginAdagio Medical revenue growthbioAffinity Technologies revenue growthAdagio Medical free cash flowbioAffinity Technologies free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.